Informa plc (LON:INF - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 828.23 ($11.07) and traded as high as GBX 942.80 ($12.61). Informa shares last traded at GBX 940.20 ($12.57), with a volume of 2,302,218 shares.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. started coverage on Informa in a report on Wednesday, September 3rd. They set an "overweight" rating and a GBX 1,020 target price on the stock. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Informa currently has a consensus rating of "Buy" and an average price target of GBX 975.
Get Our Latest Analysis on Informa
Informa Stock Down 0.4%
The stock has a market capitalization of £12.05 billion, a price-to-earnings ratio of 170.18, a PEG ratio of 0.75 and a beta of 1.12. The business has a fifty day moving average of GBX 902.84 and a 200 day moving average of GBX 828.23. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70.
Informa (LON:INF - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The company reported GBX 30.10 EPS for the quarter. Informa had a return on equity of 4.75% and a net margin of 9.30%. As a group, equities analysts predict that Informa plc will post 59.3240265 earnings per share for the current year.
Insider Buying and Selling
In related news, insider Stephen A. Carter sold 406,936 shares of the company's stock in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of GBX 865, for a total value of £3,519,996.40. Corporate insiders own 0.41% of the company's stock.
Informa Company Profile
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
